Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

EXECUTIVE SUMMARYSoft-tissue infections are common, generally of mild tomodest severity, and are easily treated with a variety ofagents. An etiologic diagnosis of simple cellulitis is fre-quently difficult and generally unnecessary for patientswith mild signs and symptoms of illness. Clinical as-sessment of the severity of infection is crucial, and sev-eral classification schemes and algorithms have beenproposed to guide the clinician [1]. However, mostclinical assessments have been developed from eitherretrospective studies or from an author’s own “clinicalexperience,” illustrating the need for prospectivestudieswith defined measurements of severity coupled to man-agement issues and outcomes.Until then, it is the recommendation of this com-mittee that patients with soft-tissue infection accom-panied by signs and symptoms of systemic toxicity (e.g.,fever or hypothermia, tachycardia [heart rate,

[1]  Philip K. Russell,et al.  Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 2000, JAMA.

[2]  A. Meheus,et al.  Horizontal transmission of hepatitis B virus , 1995, The Lancet.

[3]  N. Eke,et al.  Fournier's gangrene: a review of 1726 cases , 2000, The British journal of surgery.

[4]  D. Seal,et al.  The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas , 1985, The British journal of dermatology.

[5]  H. Mehbod,et al.  Diet in uremia. , 1971, American family physician.

[6]  L. Dimino-Emme,et al.  Cutaneous manifestations of disseminated cryptococcosis. , 1995, Journal of the American Academy of Dermatology.

[7]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[8]  G. Darmstadt,et al.  Impetigo: An Overview , 1994, Pediatric dermatology.

[9]  D. Dooley,et al.  Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. , 2004, Archives of internal medicine.

[10]  Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. , 2003, MMWR. Morbidity and mortality weekly report.

[11]  P. Cruse Wound infections epidemiology and clinical characteristics , 1988 .

[12]  A. Reingold,et al.  Toxic shock syndrome associated with surgical wound infections. , 1982, JAMA.

[13]  D. Graham,et al.  Postoperative toxic shock syndrome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  E. Goldstein,et al.  Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  R. Silver,et al.  Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis. , 1978, Archives of internal medicine.

[16]  S. Tyring,et al.  Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial , 1995, Annals of Internal Medicine.

[17]  E. Anaissie,et al.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. , 1997, Blood.

[18]  R. Raz,et al.  Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. , 1991, The Journal of infection.

[19]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[20]  J. Armitage,et al.  2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. Sheehan,et al.  Current and Emerging Azole Antifungal Agents , 1999, Clinical Microbiology Reviews.

[22]  N. Ampel Coccidioidomycosis in persons infected with HIV type 1. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  William R. Kirkpatrick,et al.  Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.

[24]  D L Stevens,et al.  Streptococcal infections of skin and soft tissues. , 1996, The New England journal of medicine.

[25]  D. Heimbach Editorial response : use of hyperbaric oxygen , 1993 .

[26]  R. Gaynes,et al.  Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  H. Meislin,et al.  Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. , 1977, Annals of internal medicine.

[28]  L. Baddour,et al.  Breast cellulitis complicating breast conservation therapy , 1999, Journal of internal medicine.

[29]  S. Shoham,et al.  Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  T J Walsh,et al.  Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  A. Reboli,et al.  Erysipelothrix rhusiopathiae: an occupational pathogen , 1989, Clinical Microbiology Reviews.

[32]  H. Hayashi,et al.  Cutaneous Mucormycosis in a Patient with Acute Lymphocytic Leukemia , 2005, The Journal of dermatology.

[33]  E. Anaissie,et al.  Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. , 2002, The New England journal of medicine.

[34]  A. Tarasi,et al.  Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae , 1990, Antimicrobial Agents and Chemotherapy.

[35]  Thomas J Walsh,et al.  Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. , 2004, The New England journal of medicine.

[36]  B. Eriksson,et al.  Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  O. Scheel,et al.  Treatment of tularemia with ciprofloxacin , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[38]  R. Facklam,et al.  Group A β-hemolytic streptococcal skin infections in a US meat-packing plant , 1987 .

[39]  R. Cody,et al.  Cellulitis after axillary lymph node dissection for carcinoma of the breast. , 1992, The American journal of medicine.

[40]  P. Adams,et al.  NCCN practice guidelines for fever and neutropenia , 1999 .

[41]  B. Krafte-Jacobs,et al.  Comparison of mupirocin and erythromycin in the treatment of impetigo. , 1990, The Journal of pediatrics.

[42]  C. Norden,et al.  Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults , 1988, Journal of clinical microbiology.

[43]  E. Fry Donald THE SURGICAL INFECTIONS , 1932, ADM; revista de la Asociacion Dental Mexicana.

[44]  M. O'Brien,et al.  Postoperative toxic shock syndrome. , 1995, American journal of orthopedics.

[45]  A. Sober,et al.  Dermatologic Manifestations of Infections in Immunocompromised Patients , 1985, Medicine.

[46]  D. Kontoyiannis,et al.  Significance of aspergillemia in patients with cancer: a 10-year study. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  J. Scheibel,et al.  Recurrent staphylococcal furunculosis in families. , 1988, Scandinavian journal of infectious diseases.

[48]  D. Bratzler,et al.  Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  W. Altemeier,et al.  Prevention and treatment of gas gangrene. , 1971, JAMA.

[50]  Kaiser Lr,et al.  ACS Surgery: Principles and Practice , 2005 .

[51]  P. Ferrieri,et al.  A controlled study of penicillin prophylaxis against streptococcal impetigo. , 1974, The Journal of infectious diseases.

[52]  I. Phillips,et al.  The aetiology of perirectal sepsis , 1982, The British journal of surgery.

[53]  J. Bouma,et al.  Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy , 1987, British journal of obstetrics and gynaecology.

[54]  Robert E. Johnson,et al.  Herpes Simplex Virus Type 2 in the United States, 1976 to 1994 , 1997 .

[55]  E. P. Dellinger,et al.  Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  M. Glauser Empiric therapy of bacterial infections in patients with severe neutropenia. , 1998, Diagnostic microbiology and infectious disease.

[57]  Chin-Ho Wong,et al.  The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections* , 2004, Critical care medicine.

[58]  P. Leaverton,et al.  Invasive Group A Streptococcal Infections in Florida , 2003, Southern medical journal.

[59]  D. Raveh,et al.  Cost-effectiveness of blood cultures for adult patients with cellulitis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  C. Baker,et al.  Red book®: 2003 report of the committee on infectious diseases. , 2016 .

[61]  H. Trau,et al.  Recurrent erysipelas: risk factors , 2004, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[62]  M. Boeckh,et al.  Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[63]  R. Wenzel,et al.  Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures , 1994, Infection Control & Hospital Epidemiology.

[64]  S. Wann,et al.  Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  C. Payá,et al.  Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  I. Shapira,et al.  Incidence of erysipelas following venectomy for coronary artery bypass surgery , 1987, Infection.

[67]  M. McDonald,et al.  Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. , 1998, The Australian and New Zealand journal of surgery.

[68]  P. Bergkvist,et al.  Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up. , 1998, Scandinavian journal of infectious diseases.

[69]  L. Magder,et al.  A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. , 1989, The New England journal of medicine.

[70]  E. Goldstein,et al.  Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. , 1999, The New England journal of medicine.

[71]  J. Dennis,et al.  Nosocomical Rhizopus infection (zygomycosis) in children. , 1980, The Journal of pediatrics.

[72]  A. Norrby-Teglund,et al.  Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  R. Dagan,et al.  Comparison of amoxicillin and clavulanic acid (augmentin) for the treatment of nonbullous impetigo. , 1989, American journal of diseases of children.

[74]  J. Hunt,et al.  Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[75]  J. E. Bennett,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .

[76]  A. Sigurdsson,et al.  The etiology of bacterial cellulitis as determined by fine-needle aspiration. , 1989, Scandinavian journal of infectious diseases.

[77]  G. Donowitz Fever in the compromised host. , 1996, Infectious disease clinics of North America.

[78]  N. Flournoy,et al.  Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. , 1980, The Journal of infectious diseases.

[79]  E. Wald,et al.  Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. , 2002, The New England journal of medicine.

[80]  S. Peterson,et al.  Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy. , 2005, Cutis.

[81]  J. Rhoads,et al.  Surgery : principles and practice , 1962 .

[82]  J. Wingard,et al.  Candida tropicalis: a major pathogen in immunocompromised patients. , 1979, Annals of internal medicine.

[83]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  Lewis Rt Necrotizing soft-tissue infections. , 1992 .

[85]  E. Goldstein,et al.  Outpatient Therapy of Bite Wounds , 1987, International Journal of Dermatology.

[86]  Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. , 1991, The Journal of infectious diseases.

[87]  F. Witebsky,et al.  Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. , 1982, The American journal of medicine.

[88]  Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  J. Vardiman,et al.  Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. , 1986, The American journal of medicine.

[90]  A. Knight,et al.  Cutaneous cryptococcosis: treatment with oral fluconazole , 1989, The British journal of dermatology.

[91]  M. Kielhofner,et al.  Influence of underlying disease process on the utility of cellulitis needle aspirates. , 1988, Archives of internal medicine.

[92]  G. Sarosi,et al.  Disseminated histoplasmosis in renal transplant recipients. , 1979, American journal of surgery.

[93]  E. Kaplan,et al.  Suppression of the antistreptolysin O response by cholesterol and by lipid extracts of rabbit skin , 1976, The Journal of experimental medicine.

[94]  R. Schneider,et al.  Invasive Aspergillus infections in a pediatric hospital: a ten‐year review , 1993, The Pediatric infectious disease journal.

[95]  H. Stone,et al.  Prophylactic and Preventive Antibiotic Therapy Timing, Duration and Economics , 1979, Annals of surgery.

[96]  T. Brennan,et al.  INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED PATIENTS , 2008 .

[97]  E. Loh,et al.  The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[98]  G. Scott,et al.  Diagnosis of cutaneous cytomegalovirus infection: a review and report of a case. , 1991, Journal of the American Academy of Dermatology.

[99]  A. Trott,et al.  Microbiology of adult cellulitis. , 1988, The Journal of family practice.

[100]  R. Jacobs,et al.  Streptomycin and alternative agents for the treatment of tularemia: review of the literature. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[101]  Robert S. Daum,et al.  Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2002, Antimicrobial Agents and Chemotherapy.

[102]  J. Hirschmann Impetigo: etiology and therapy. , 2002, Current clinical topics in infectious diseases.

[103]  W. J. Martin,et al.  Prophylaxis of recurrent lymphangitis complicating lymphedema. , 1966, JAMA.

[104]  Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[105]  Gina Pugliese,et al.  Anthrax as a Biological Weapon: Medical and Public Health Management , 1999 .

[106]  E. Zook,et al.  Successful treatment protocol for canine fang injuries. , 1980, The Journal of trauma.

[107]  D. Schlossberg Current therapy of infectious disease , 1996 .

[108]  L. Vaillant,et al.  Risk factors for erysipelas of the leg (cellulitis): case-control study , 1999, BMJ.

[109]  G. Sarosi,et al.  Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[110]  R. Kasseroller Sodium selenite as prophylaxis against erysipelas in secondary lymphedema. , 1998, Anticancer research.

[111]  E. Kaplan,et al.  The influence of the site of infection on the immune response to group A streptococci. , 1970, The Journal of clinical investigation.

[112]  Transmission of HIV by human bite. , 1987, Lancet.

[113]  D. McRitchie Review for Surgery: Scientific Principles and Practice , 1997 .

[114]  B. Corrin,et al.  Anaerobic axillary abscess. , 1979, British medical journal.

[115]  A. Sober,et al.  Dermatologic manifestations of infection in the compromised host. , 1983, Annual review of medicine.

[116]  B. Lebeau,et al.  Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[117]  E Rubinstein,et al.  Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[118]  Michael L Wilson,et al.  Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  R. Kaul,et al.  Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study , 1999 .

[120]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[121]  H. Fukuda,et al.  European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .

[122]  E. Reed,et al.  Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. , 1991, The Journal of infectious diseases.

[123]  W R Jarvis,et al.  Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. , 1999, Infection control and hospital epidemiology.

[124]  M. Paesmans,et al.  Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[125]  Edgar B. Smith,et al.  Bacteriology of inflamed and uninflamed epidermal inclusion cysts. , 1998, Archives of dermatology.

[126]  Benjamin A Lipsky,et al.  Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization with Staphylococcus aureus. , 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[127]  F. Schildberg,et al.  Klebsiella pneumoniae Necrotizing F asciitis Associated w ith D iabetes a nd L iver C irrhosis , 2000 .

[128]  W. Huizinga,et al.  The value of adjuvant systemic antibiotic therapy in localised wound infections among hospital patients: a comparative study. , 1986, The Journal of infection.

[129]  J. Bouma,et al.  Recurrent acute leg cellulitis in patients after radical vulvectomy. , 1988, Gynecologic oncology.

[130]  T. Riley,et al.  Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. , 1999, Journal of medical microbiology.

[131]  T. Walsh,et al.  Trichosporonosis in Patients with Neoplastic Disease , 1986, Medicine.

[132]  M. Egger,et al.  Nocardial infections in the immunocompromised host: A detailed study in a defined population. , 1981, Reviews of infectious diseases.

[133]  D. Stevens,et al.  Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections , 2000, Antimicrobial Agents and Chemotherapy.

[134]  E. Goldstein New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds. , 1998, Journal of medical microbiology.

[135]  J. W. Bass,et al.  Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. , 1990, American journal of diseases of children.

[136]  E. Anaissie Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[137]  J. Miller,et al.  Primary cutaneous aspergillosis associated with Hickman intravenous catheters. , 1987, The New England journal of medicine.

[138]  F. Vandenesch,et al.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[139]  R. Finberg,et al.  Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1999, The New England journal of medicine.

[140]  E. Anaissie,et al.  Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[141]  B. Bean,et al.  Acyclovir halts progression of herpes zoster in immunocompromised patients. , 1983, The New England journal of medicine.

[142]  P. Riegels-Nielsen,et al.  [Fournier's gangrene]. , 1984, Ugeskrift for laeger.

[143]  G. Bodey,et al.  Skin lesions associated with disseminated candidiasis. , 1974, JAMA.

[144]  R. Finberg,et al.  Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia , 1999 .

[145]  M. York,et al.  Characterization of Antimicrobial Resistance inStreptococcus pyogenes Isolates from the San Francisco Bay Area of Northern California , 1999, Journal of Clinical Microbiology.

[146]  A. Halstensen,et al.  Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features , 1994, The Lancet.

[147]  D. Anderson,et al.  Cryptococcal disease presenting as cellulitis. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[148]  R. Nichols Postoperative wound infection. , 1982, The New England journal of medicine.

[149]  Brad Spellberg,et al.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. , 2005, The New England journal of medicine.

[150]  C. V. Beneden Erythromycin Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2001 , 2004 .

[151]  J. Roujeau,et al.  Roxithromycin verseus penicillin in the treatment of erysipelas in adults: a comparative study , 1992, The British journal of dermatology.

[152]  B. Brandt,et al.  Textbook of Surgery: The Biological Basis of Modern Surgical Practice , 1987 .

[153]  D. Lauderdale,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.

[154]  G. Keusch,et al.  Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. , 1978, The New England journal of medicine.

[155]  R. Locksley,et al.  Infection with varicella-zoster virus after marrow transplantation. , 1985, The Journal of infectious diseases.

[156]  J. Heitman Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .

[157]  Y. Fong,et al.  ACS Surgery: Principles and Practice , 2007 .

[158]  M. Swartz,et al.  Clinical practice. Cellulitis. , 2004, The New England journal of medicine.

[159]  D. Stevens,et al.  Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens , 1987, Antimicrobial Agents and Chemotherapy.

[160]  Larry K. Pickering,et al.  General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[161]  D. Stevens,et al.  Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. , 1987, The Journal of infectious diseases.

[162]  R L Menlove,et al.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. , 1992, The New England journal of medicine.

[163]  J. Sobel,et al.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[164]  T. Merigan,et al.  Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. , 1980, The Journal of clinical investigation.

[165]  P. Bergkvist,et al.  Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. , 1997, Scandinavian journal of infectious diseases.

[166]  J. Bonnetblanc,et al.  Early detection of streptococcal group antigens in skin samples by latex particle agglutination. , 1987, Archives of dermatology.

[167]  B. Bobrow,et al.  Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults. , 1997, Annals of emergency medicine.

[168]  R. Raz,et al.  A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. , 1996, Archives of internal medicine.

[169]  J. Semel,et al.  Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[170]  Y. Kitajima,et al.  Skin infection caused by Mycobacterium avium , 1997, The British journal of dermatology.

[171]  R. Wenzel Perspective: Attributable mortality--the promise of better antimicrobial therapy. , 1998, The Journal of infectious diseases.

[172]  N. Fiumara,et al.  Primary syphilis following a human bite. , 1981, Sexually transmitted diseases.

[173]  G. Samonis,et al.  Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. , 2000, Archives of internal medicine.

[174]  M. Poljak,et al.  Transmission of HIV-1 by human bite , 1996, The Lancet.

[175]  F. W. Blaisdell,et al.  Bacteriology of necrotizing fasciitis. , 1977, American journal of surgery.

[176]  T. Hooton,et al.  Microbiologic evaluation of cutaneous cellulitis in adults. , 1986, Archives of internal medicine.

[177]  J. Šufliarský,et al.  Fungaemia due to Fusarium spp. in cancer patients. , 1997, The Journal of hospital infection.

[178]  Benjamin A Lipsky,et al.  Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization withStaphylococcus aureus , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[179]  J. Bonnetblanc,et al.  Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. , 1989, Archives of dermatology.

[180]  F. Dromer,et al.  Primary cutaneous cryptococcosis: a distinct clinical entity. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[181]  D. Denning,et al.  Practice Guidelines for Diseases Caused by Aspergillus , 2000 .

[182]  M. A. Martin,et al.  Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. , 1989, Annals of internal medicine.

[183]  M. Sachs The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. , 1990, Archives of internal medicine.

[184]  Hilary L Reich,et al.  Nonpseudomonal ecthyma gangrenosum. , 2004, Journal of the American Academy of Dermatology.

[185]  B. Goldstein,et al.  Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[186]  T. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. , 1999, American journal of infection control.

[187]  D. Denning,et al.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[188]  C. Jorup-Rönström,et al.  Antibiotic prophylaxis in recurrent erysipelas , 1993, Infection.

[189]  R. Wallace,,et al.  Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. , 1992, The Journal of infectious diseases.

[190]  D. Watkin,et al.  POSTOPERATIVE WOUND INFECTION. , 1965, Lancet.

[191]  E. Goldstein Bite wounds and infection. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[192]  D. Stevens Dilemmas in the treatment of invasive Streptococcus pyogenes infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[193]  G. Bodey,et al.  Nocardial infection in patients with neoplastic disease. , 1989, Reviews of infectious diseases.

[194]  R. Burkitt Tropical pyomyositis. , 1947, The Journal of tropical medicine and hygiene.

[195]  R. Briggaman,et al.  Cutaneous manifestations of disseminated cryptococcosis. , 1976, Archives of dermatology.

[196]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[197]  A. Sjöstedt,et al.  Ciprofloxacin for treatment of tularemia in children , 2000, The Pediatric infectious disease journal.

[198]  Amy V. Groom,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. , 2001, JAMA.

[199]  C. Jorup-Rönström,et al.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas , 1984, Infection.

[200]  C. Chartier,et al.  ERYSIPELAS: AN UPDATE , 1996, International journal of dermatology.

[201]  John D. Turnidge,et al.  Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community , 2002, Journal of Clinical Microbiology.

[202]  J. Bartlett Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. , 2003, MMWR. Morbidity and mortality weekly report.

[203]  I. Phillips,et al.  The aetiology of scrotal sepsis , 1982, The British journal of surgery.

[204]  S J Lin,et al.  Aspergillosis case-fatality rate: systematic review of the literature. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[205]  A. Bisno,et al.  Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. , 1982, Annals of internal medicine.

[206]  J. Burke The effective period of preventive antibiotic action in experimental incisions and dermal lesions. , 1961, Surgery.

[207]  L. Elting,et al.  Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[208]  Bhushan Kumar,et al.  The Pattern of Mucocutaneous Infections and Infestations in Renal Transplant Recipients , 2003, The Journal of dermatology.

[209]  S. A. Hedström,et al.  Recurrent staphylococcal furunculosis. Bacteriological findings and epidemiology in 100 cases. , 1981, Scandinavian journal of infectious diseases.

[210]  J. Wade,et al.  Management of infection in patients with acute leukemia. , 1993, Hematology/oncology clinics of North America.

[211]  A. Marsden,et al.  Aerobic and anaerobic bacteriology of subcutaneous abscesses , 1981, The British journal of surgery.

[212]  L. Weinstein,et al.  Does antimicrobial therapy of streptococcal pharyngitis or pyoderma alter the risk of glomerulonephritis? , 1971, The Journal of infectious diseases.

[213]  E. Swierkosz,et al.  Impetigo Contagiosa III. Comparative Efficacy of Oral Erythromycin and Topical Mupirocin , 1989, Pediatric dermatology.

[214]  M. Weisse,et al.  Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. , 1998, The Pediatric infectious disease journal.

[215]  W. Pan,et al.  ERYSIPELAS , 1935 .

[216]  Horizontal transmission of hepatitis B virus , 1991 .

[217]  P. Pizzo,et al.  Management of fever in patients with cancer and treatment-induced neutropenia. , 1993, The New England journal of medicine.

[218]  NCCN practice guidelines for fever and neutropenia. National Comprehensive Cancer Network. , 1999, Oncology.

[219]  A. A. Eddy,et al.  Note added in proof: Mechanisms of solute transport in selected eukaryotic micro-organisms , 1982 .

[220]  S. Y. Kim,et al.  Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital. , 2003, The Journal of antimicrobial chemotherapy.

[221]  L. Barton,et al.  Impetigo: A Reassessment of Etiology and Therapy , 1987, Pediatric dermatology.

[222]  Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. , 2003, MMWR. Morbidity and mortality weekly report.

[223]  J. Macfie,et al.  The treatment of acute superficial abscesses: A prospective clinical trial , 1977, The British journal of surgery.

[224]  C. Edmiston,et al.  The nonpuerperal breast infection: aerobic and anaerobic microbial recovery from acute and chronic disease. , 1990, The Journal of infectious diseases.

[225]  R. Levy,et al.  Treatment of cutaneous abscess: a double-blind clinical study. , 1985, Annals of emergency medicine.

[226]  J. Todd,et al.  Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. , 1999, The Pediatric infectious disease journal.

[227]  R. Perry,et al.  Yersinia pestis--etiologic agent of plague , 1997, Clinical microbiology reviews.

[228]  C. A. M. Cotlar Surgery: Scientific Principles and Practice , 1997 .

[229]  E. Goldstein,et al.  Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. , 2001, The Journal of antimicrobial chemotherapy.

[230]  I. Brook,et al.  Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. , 1990, Archives of surgery.

[231]  T. Cleary,et al.  Disseminated Mycobacterium avium-intracellulare infection appearing as a panniculitis. , 1982, Archives of pathology & laboratory medicine.

[232]  J. May Surgery: Scientific principles and practice , 1997 .

[233]  T. Calandra,et al.  Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .

[234]  H. Gallis,et al.  Trimethoprim-sulfamethoxazole therapy for Nocardia infections. , 1983, Archives of internal medicine.

[235]  J. Sobel,et al.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[236]  T. V. Venkatesan Impetigo contagiosa. , 1946, The Antiseptic.

[237]  B. Adams Dermatologic Disorders of the Athlete , 2002, Sports medicine.

[238]  R. Kirsner,et al.  The clinical spectrum of lipodermatosclerosis. , 1993, Journal of the American Academy of Dermatology.

[239]  C. Sanders,et al.  Dermatologic infections in the immunocompromised (non-HIV) host. , 2001, Infectious disease clinics of North America.

[240]  H. Balfour,et al.  Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. , 1994, Journal of acquired immune deficiency syndromes.

[241]  H. Meislin Pathogen identification of abscesses and cellulitis. , 1986, Annals of emergency medicine.

[242]  F. Meunier Empirical antifungal therapy in febrile granulocytopenic patients , 1989 .

[243]  W K Vaughn,et al.  An outbreak of staphylococcal skin infections among river rafting guides. , 1986, American journal of epidemiology.

[244]  D. Banker,et al.  Nosocomial infection. , 1994, Indian journal of medical sciences.

[245]  T. C. White,et al.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.

[246]  L. Saravolatz,et al.  Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection , 1992, Annals of Internal Medicine.

[247]  D. Bratzler,et al.  Antimicrobial Prophylaxis for Surgery: An Advisory Statement from the National Surgical Infection Prevention Project , 2004 .

[248]  E. Goldstein,et al.  Bacteriology of human and animal bite wounds , 1978, Journal of clinical microbiology.

[249]  P. Schlievert,et al.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. , 1989, The New England journal of medicine.

[250]  E. Anaissie,et al.  Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[251]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.

[252]  J. Roujeau,et al.  Value of fine-needle aspiration in infectious cellulitis. , 1996, Archives of dermatology.

[253]  P. Scheuer,et al.  Hepatitis C virus transmitted by human bite , 1990, The Lancet.

[254]  N. Cox Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow‐up , 2006, The British journal of dermatology.

[255]  A. Dajani,et al.  Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. , 1972, The Journal of clinical investigation.

[256]  A. Bisno,et al.  Factors influencing serum antibody responses in streptococcal pyoderma. , 1973, The Journal of laboratory and clinical medicine.

[257]  C. Jorup-Rönström,et al.  Erysipelas: clinical and bacteriologic spectrum and serological aspects. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[258]  Philip K. Russell,et al.  Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.

[259]  J. Wingard,et al.  Differences between first and subsequent fevers during prolonged neutropenia , 1987, Cancer.

[260]  Rivera Jo,et al.  Microbiology of adult cellulitis. , 1988 .

[261]  D. Joyce An outbreak of furunculosis among high school athletes. , 1990, The American journal of sports medicine.

[262]  A. Bisno,et al.  Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. , 1984, JAMA.

[263]  D. Stevens,et al.  Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[264]  N. Crum Bacterial pyomyositis in the United States. , 2004, The American journal of medicine.

[265]  L. Corey,et al.  Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. , 1996, The Journal of infectious diseases.

[266]  R. Wenzel,et al.  Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[267]  L. Mermel,et al.  Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control & Hospital Epidemiology.

[268]  J. Pérez-Castrillón,et al.  Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.